β-catenin-IN-6是一种通过靶向Wnt通路起作用的β-catenin抑制剂，能在人类结直肠癌细胞及β-catenin/RK3E小鼠模型中有效抑制增殖。
[1] Dehnhardt CM, Venkatesan AM, Chen Z, Ayral-Kaloustian S, Dos Santos O, Delos Santos E, Curran K, Follettie MT, Diesl V, Lucas J, Geng Y, Dejoy SQ, Petersen R, Chaudhary I, Brooijmans N, Mansour TS, Arndt K, Chen L. Design and synthesis of novel diaminoquinazolines with in vivo efficacy for beta-catenin/T-cell transcriptional factor 4 pathway inhibition. J Med Chem. 2010 Jan 28;53(2):897-910. doi: 10.1021/jm901370m. PMID: 20025292.[2]McCoy MA, Spicer D, Wells N, Hoogewijs K, Fiedler M, Baud MGJ. Biophysical Survey of Small-Molecule β-Catenin Inhibitors: A Cautionary Tale. J Med Chem. 2022 May 26;65(10):7246-7261. doi: 10.1021/acs.jmedchem.2c00228. Epub 2022 May 17. PMID: 35581674; PMCID: PMC9150122.
